SCHEMBL7478358

SCHEMBL7478358

Nc1[nH]nc(-c2ccc(F)cc2F)c1C(=O)c1cccc(C#CC2(O)CCCC2)c1

nearest known ligand 0.40

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 11/20 0.40
GRM5 P41594 3/20 0.38
ALOX15 P16050 1/20 0.37
PRKD1 Q15139 1/20 0.35
ADORA2A P29274 3/20 0.33
ADORA2B P29275 3/20 0.33
ADORA1 P30542 3/20 0.33
ADORA3 P0DMS8 2/20 0.33
MAPK14 Q16539 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7478209 0.88 MAP3K14 (0.41) MAP3K14GRM5PRKD1ADORA2AADORA2B
SCHEMBL7478407 0.81 MAPK14 (0.39) GRM5ALOX15MAPK14
SCHEMBL7482460 0.79 MAPK14 (0.53) ALOX15MAPK14
SCHEMBL7464576 0.77 ALOX15 (0.47) ALOX15MAPK14
SCHEMBL7474793 0.77 ALOX15 (0.44) ALOX15MAPK14
SCHEMBL7480688 0.75 ALOX15 (0.43) ALOX15MAPK14
SCHEMBL7473891 0.73 MAPK14 (0.52) ALOX15ADORA2AADORA2BADORA1ADORA3
SCHEMBL7475964 0.73 CYP2D6 (0.47) ALOX15
SCHEMBL6158445 0.73 MAPK14 (0.58) MAPK14
SCHEMBL7479297 0.72 MAPK14 (0.54) ALOX15MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218346-A1 PYRAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-07-03 EP disclosed
WO-2001021591-A1 PYRAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2001-03-29 WO disclosed
EP-1075467-A1 PYRAZOLE DERIVATIVES AS P-38 MAP KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2001-02-14 EP disclosed
WO-1999057101-A1 PYRAZOLE DERIVATIVES AS P-38 MAP KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 1999-11-11 WO disclosed